Administer’s H2 figures were well in line with our expectations, with revenue of EUR 22.
Redeye initiates coverage of Sedana Medical, a medtech/pharma company challenging the standard of ca...
Fjärde kvartalet 2021 bjöd på väsentligt lägre intäkter än våra prognoser.
Redeye comments on Fluoguide’s Q4 report, following a relatively calm couple of months on the news f...
Redeye comments on today's CEO announcement
Annexin Pharmaceuticals held a Strategy Update on the 30th of March.
During 2021 OrderYOYO has experienced solid growth in ARR from both existing and new Restaurant Part...
Genom att kombinera organisk expansion och strategiska förvärv ska Anima Group växa under lönsamhet ...
Redeye updates its view on Cantargia following a period that has brought promising trial results and...
FlexQube had a busy day yesterday announcing a new deal with Tesla, a large follow-up order for eQar...
IAR Systems is gradually taking the necessary steps to turn around the soft operating momentum, whic...
Redeye is discouraged by yesterday’s drastic announcement of a strategic reprioritization and thus p...
Redeye resumes coverage following the rights issue raising SEK 69m for NeoDynamics.
Idag offentliggjorde InCoax sin delårsrapport för fjärde kvartalet 2021.
Nitro games signed an additional B2B development deal, this time with Metacore Games.
Analyst Group har med Anima Group ingått avtal om kontinuerlig analysbevakning, innefattande bl.
Orderingång är exceptionellt stark... Efterfrågan för Beijer Groups produkter fortsätter vara except...
Redeye views the submittal of the full application of the marketing authorization for MOB-015 as pos...
Den virtuella satellitnätsoperatören för IoT Wyld Networks, avslutade 2021 starkt med flera nya sama...
The virtual satellite network operator IoT Wyld Networks ended 2021 strongly with several new collab...
